Insights

Home Use Opportunity Position NeoSync NEST as a consumer-facing, at-home TMS solution to expand treatment access for major depressive disorder, targeting patients who face barriers to in-clinic sessions and care continuity.

Clinical Validation Leverage the completed 200-patient randomized, multi-center trial and favorable safety profile to engage payers and clinics with a proven efficacy and tolerability narrative that supports broader adoption and potential reimbursement.

Regulatory Path Highlight ongoing efforts toward FDA 510(k) clearance for home use to prospective partners and distributors, signaling a near-term regulatory milestone that can unlock new sales channels.

Market Differentiator Emphasize NEST’s personalized alpha-frequency EEG synchronization as a unique selling point to differentiate from standard TMS devices and attract clinics seeking tailored depression therapies and improved patient outcomes.

Strategic Partnerships Target collaborations with neuromodulation clinics, academic centers, and healthcare systems that can pilot home-use TMS programs, expand access, and drive scale through bundled offerings and potential volume uptake.

Similar companies to NeoSync, Inc.

NeoSync, Inc. Tech Stack

NeoSync, Inc. uses 2 technology products and services including Google Fonts API, jQuery, and more. Explore NeoSync, Inc.'s tech stack below.

  • Google Fonts API
    Font Scripts
  • jQuery
    Javascript Libraries

NeoSync, Inc.'s Email Address Formats

NeoSync, Inc. uses at least 1 email format:
NeoSync, Inc. Email FormatsExamplePercentage
FLast@neosync.comJDoe@neosync.com
100%

Frequently Asked Questions

What is NeoSync, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
NeoSync, Inc.'s official website is neosync.com and has social profiles on LinkedIn.

How much revenue does NeoSync, Inc. generate?

Minus sign iconPlus sign icon
As of September 2026, NeoSync, Inc.'s annual revenue is estimated to be <$1M.

What is NeoSync, Inc.'s NAICS code?

Minus sign iconPlus sign icon
NeoSync, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does NeoSync, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2026, NeoSync, Inc. has approximately 4 employees across 2 continents, including Europe and North America. Key team members include Member Of The Board: J. P. Explore NeoSync, Inc.'s employee directory with LeadIQ.

What industry does NeoSync, Inc. belong to?

Minus sign iconPlus sign icon
NeoSync, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does NeoSync, Inc. use?

Minus sign iconPlus sign icon
NeoSync, Inc.'s tech stack includes Google Fonts API and jQuery.

What is NeoSync, Inc.'s email format?

Minus sign iconPlus sign icon
NeoSync, Inc.'s email format typically follows the pattern of FLast@neosync.com. Find more NeoSync, Inc. email formats with LeadIQ.

How much funding has NeoSync, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2026, NeoSync, Inc. has raised $13M in funding. The last funding round occurred on Aug 10, 2017.

When was NeoSync, Inc. founded?

Minus sign iconPlus sign icon
NeoSync, Inc. was founded in 2008.
NeoSync, Inc. logo

NeoSync, Inc.

Medical Equipment ManufacturingMassachusetts, United States2-10 Employees

NeoSync, Inc. is a clinical-stage medical device company based in Boston, Massachusetts, founded in 2008. It is developing personalized transcranial magnetic stimulation for the treatment of Major Depressive Disorder and other central nervous system diseases, aiming to address the limitations of current pharmacological therapies and non-pharmacological options. The company’s NEST system delivers low-energy, EEG-guided magnetic stimulation in daily sessions and is designed to be tailored to an individual’s brain activity, with the goal of improving safety and tolerability compared with existing treatments. NeoSync has progressed through a pilot study and a larger randomized, multi-center trial, and it is advancing a clinical study to support a planned submission for FDA clearance of the NEST device for home use. The target market includes adults affected by depression and other CNS conditions, particularly those who may not respond adequately to standard antidepressants or who could benefit from at-home treatment options. NeoSync operates within the medical equipment manufacturing sector, aligning its development with a growing but still emerging market for transcranial magnetic stimulation therapies.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2008
Employees
2-10

Section iconFunding & Financials

  • $13M

    NeoSync, Inc. has raised a total of $13M of funding over 1 rounds. Their latest funding round was raised on Aug 10, 2017 as a Series D.

  • <$1M

    NeoSync, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.